The atypical antipsychotics and sexual dysfunction: a pharmacovigilance-pharmacodynamic study
Frontiers in Pharmacology · 09.07.2024 · 15
DOI: 10.3389/fphar.2024.1423075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 09.07.2024. Verfasst von Yu Cheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Atypical antipsychotics (AAPs)-induced sexual dysfunction (SD) is a frequent issue in clinical practice, often underestimated by clinicians and not extensively researched. The current study aimed to quantify the strength of association between the use of different AAPs and SD using real-world data from the FDA Adverse Event Reporting System (FAERS), as well as investigate the receptor mechanisms that are involved.
Methods
Data from the FAERS database from the first quarter of 2004 to the third quarter of 2023 were queried through OpenVigil 2.1. Disproportionality analysis was estimated using the reporting odds ratio (ROR) and information component (IC) methods, and linear regression was used to investigate the relationship between ROR and receptor occupancy which was estimated using in vitro receptor binding profiles.
Results
Our analysis yielded 4839 reports that co-mentioned AAP and SD events, and the findings revealed statistical associations between 12 AAPs and SD. The highest signal value was identified for iloperidone reporting retrograde ejaculation with iloperidone (ROR = 832.09, ROR 025 = 552.77; IC = 9.58, IC 025 = 6.36), followed by compulsive sexual behavior with aripiprazole (ROR = 533.02, ROR 025 = 435.90; IC = 7.30, IC 025 = 5.97), and psychosexual disorder for aripiprazole (ROR = 145.80, ROR 025 = 109.57; IC 025 = 6.47, IC025 = 4.86). Different characteristics of the SD side effects in each AAPs were discovered after further data mining. Regression analysis revealed potential effects for receptor occupancy of D2, D3, and 5-HT1A receptors on ROR. However, no significant correlation persisted following sensitivity analyses.
Conclusion
This is the first study to investigate the AAP-SD associations by using FAERS. In this study, we report for the first time a significant association between aripiprazole and SD based on real-world data. The study suggests that different AAPs have varying levels of association with SD, and the D2, D3, and 5-HT1A receptor occupancy may contribute to potential mechanisms. The findings of this study warrant further validation of more studies and clinical causality assessment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zitieren
APA
Cheng, Y., Chen, Y., Zhao, X., Mou, F., Wang, W., Qian, R., Huang, J., Li, H., Xu, Q., & Yu, S. (2024). The atypical antipsychotics and sexual dysfunction: a pharmacovigilance-pharmacodynamic study. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1423075
Vancouver
Cheng Y, Chen Y, Zhao X, Mou F, Wang W, Qian R, et al. The atypical antipsychotics and sexual dysfunction: a pharmacovigilance-pharmacodynamic study. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1423075
BibTeX
@article{Cheng2024,
author = {Cheng, Yu and Chen, Youjun and Zhao, Xue and Mou, Fan and Wang, Wanying and Qian, Ruiyi and Huang, Jingjing and Li, Huafang and Xu, Qingqing and Yu, Shunying},
title = {The atypical antipsychotics and sexual dysfunction: a pharmacovigilance-pharmacodynamic study},
journal = {Frontiers in Pharmacology},
year = {2024},
volume = {15},
doi = {10.3389/fphar.2024.1423075}
}
EUVIMED